Summary List Placement
Global stocks jumped on Monday, boosted by a newly positive COVID-19 vaccine backdrop and stronger industrial data from China.
Investors are eagerly anticipating results from vaccine candidates including Moderna, AstraZeneca, and Janssen.
“The road to full economic reopening is slow, but the ‘long vaccine’ trade remains live,” Axi’s chief market strategist said.
President Donald Trump plans to introduce fresh sanctions against China and promote hawkish government officials to senior roles before his term ends, according to Axios.
Visit Business Insider’s homepage for more stories.
Global stocks rose on Monday as investors were encouraged by more positive news on the COVID-19 vaccine front and strong factory data from China.
Futures tied to the Dow Jones, S&P 500, and Nasdaq rose between 0.5% and 0.9%.
Ugur Sahin, the CEO of Pfizer’s vaccine partner BioNTech, said COVID-19 will be reduced by about 50% following the vaccine rollout, and could result in a “dramatic reduction of the pandemic spread.”
Moderna is expected to soon release the results of its vaccine, called mRNA-1273. Dr. Anthony Fauci has said he would be surprised if the data is not similar to Pfizer’s.
A third vaccine being developed by Janssen, a subsidiary of Johnson & Johnson, …read more
Source:: Businessinsider – Finance